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EVALUATION OF LIFESTYLE MODIFICATION
Abstract
Problem: Polycystic Ovary Syndrome (PCOS) affects a large proportion of the female
population worldwide. PCOS can have a wide variety of health implications for the
woman including difficulty achieving pregnancy.
Methods: A retrospective chart review of 368 patient records were assessed for inclusion
criteria yielding 163 patients with PCOS suffering from infertility. Demographic and
health data were gathered for each patient to provide a baseline comparison between the
first two quarters of 2019 and the first two quarters of 2020.
Results: The results of the study were mixed. Patients who lost weight did have a higher
positive pregnancy rate. However, as a byproduct of the study it was found that the
Health and Wellness program is being underutilized and is using only a single modality
for treatment. The clinic is losing patients due to a lack of follow-up and there are
communications disconnect between the Health and Wellness program and the clinic.
Implications for Practice: The study has shown that weight loss does help improve
positive pregnancy rates. The study also identified some areas of improvement that needs
to be addressed in the Health and Wellness program. Implementing a more well-rounded
and holistic program by adding components to address physical activity, stress reduction,
and mental and physical health oversight would transform the Health and Wellness
program into a true lifestyle modification program.
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Evaluation of Lifestyle Modification Program for Polycystic Ovary Syndrome in Infertile
Women
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and
metabolic disorders existent in women (Bozdag, Mumusoglu, & Zengin, 2016). PCOS
effects women of all ages, income levels, ethnicities, and education levels. Studies
performed in North America, Europe, Australia, and Asia revealed approximately 5-21%
of the population has PCOS (Arasu, Moran, Robinson, Boyle, & Lim, 2019; Bozdag,
Mumusoglu, & Zengin, 2016; Regidor & Schindler, 2016). Many women with PCOS are
misdiagnosed or never referred for treatment by their primary care providers (Tomlinson
et al., 2017).
The etiology of PCOS is fascinating. The evolving consensus among leading
experts in the field is that PCOS is an evolutionary advantage developed through natural
selection during periods of nutritional shortages (Shaw & Rosenfield, 2020). This
advantage was critical to survival because it increased the body’s ability to preserve
anabolism and reproductive ability by way of increasing androgen and insulin production
thus promoting fat storage (Shaw & Rosenfield, 2020). The increased ability to retain fat
allowed women to still be capable of reproduction when others would fall below the
needed fat levels to ovulate. In the modern times when food is plentiful and where
starvation is unlikely this trait leads to obesity and other associated medical issues,
including infertility (Shaw & Rosenfield, 2020).
Today PCOS is recognized as a disorder with complex genetic attributes in which
environmental issues and multiple different genes result in the development of a
syndrome that has a multitude of complications in a variety of body systems (Bozdag,
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Mumusoglu, & Zengin, 2016). There are currently three diagnostic criteria in use for
classifying and diagnosing PCOS (Tannus, Tan, Son, & Dahan, 2017). They are the
Rotterdam criteria, Androgen excess and PCOS society criteria, and the National Institute
of Health (NIH) criteria (Bozdag, Mumusoglu, & Zengin, 2016; Tannus et al., 2017). For
the diagnosis of PCOS the most commonly used criteria is the Rotterdam (Genazzani,
2016). The Rotterdam criteria require at least two of three features be present for
diagnosis; these are oligo or anovulation, polycystic ovary morphology, and clinical or
chemical symptoms of hyperandrogenism (hirsutism, acne, male-pattern hair loss)
(Bergh, Moore, & Gundell, 2016; Bozdag, Mumusoglu, & Zengin, 2016; Tannus et al.,
2017). Up to 18% of patients with PCOS do not manifest hyperandrogenism (Tannus et
al., 2017). In addition to the three primary manifestations of PCOS, there also exists a
higher risk for other life altering ramifications including heightened risk of infertility,
diabetes mellitus, metabolic syndrome, cardiovascular disease, endometrial cancer, and
psychological issues (Arasu et al., 2019; Shaw & Rosenfield, 2020; Tomlinson et al.,
2017). However, social determinants of health (SDOH) (examples include income,
location and insurance status) strongly impact a woman’s ability pay for medical care to
reduce the impact of these risk factors (King et al., 2016). The patient’s ability to receive
treatment, despite potential SDOH, for PCOS manifestations can help reduce obesity
resulting in a higher chance of becoming pregnant (Arasu et al., 2019).
The purpose of this descriptive study project is to evaluate the impact of a
treatment regime consisting of lifestyle modifications and pharmaceutical aids in
assisting infertile women of reproductive age with PCOS becoming pregnant. The overall
aim of this project is to evaluate an existing lifestyle modification program to determine
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if it assists infertile women with PCOS achieve pregnancy in at least 10% of cases during
a 12-month period. The primary outcome measure of interest will be the rate of positive
pregnancies achieved. Secondary outcome measures will be the resumption of menstrual
cycle, weight change, attendance in lifestyle modification program, patient retention data
and demographic information. These variables will be evaluated via a retrospective chart
review from patients who took part in the lifestyle modification program during the first
two quarters of 2020 and historical chart review from the first two quarters of 2019 prior
to implementing the Lifestyle Modification Program. The question for study is in infertile
women aged 18- to 39 -years with PCOS, what is the impact of lifestyle modification and
medication for fertility on the ability to conceive within six-months of the treatment?
This will be a Plan-Do-Study-Act Cycle (PDSA) descriptive study.
Literature Review
Preparation for the literature review started with research using a general UMSL
library database search, CINAHL, Cochrane, Ovid Medline, and Wiley. Key search terms
used were pcos OR polycystic ovary syndrome OR polycystic ovarian syndrome OR
ovarian follicle, AND pregnancy, AND fertility, AND treatment OR intervention OR
therapy OR management. The initial search in CINAHL for pcos OR polycystic ovary
syndrome OR polycystic ovarian syndrome OR ovarian follicle, generated 6155 results.
For inclusion criteria the search was limited to articles from 2005 to 2020, included only
peer reviewed articles, and added the term ‘human’. Terms including cancer patients,
Turners and Fowlers were excluded. These resulted in 212 articles for consideration.
After individually evaluating the remaining articles for relevance to the project topic, 24
were chosen to be included in this literature review.
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Insulin resistance and the associated hyperinsulinemia appears to be a key feature
in the pathology of PCOS and reinforces reproductive and endocrine features such as
hyperandrogenism and ovarian dysfunction (Arasu et al., 2019; Cassar et al., 2016; Song,
Hong, Sung, & Lee, 2017). This insulin resistance leads to the disruption of
gonadotrophin secretion and paradoxically insulin stimulates androgen production by the
insulin sensitive ovaries leading to infertility and other symptoms of PCOS (Cassar et al.,
2016; Rosenfield & Ehrmann, 2016). The overabundance of androgens hinders follicle
growth and ovulation that causes ovarian follicles to freeze at the preovulation stage
(Bergh et al., 2016).
Insulin resistance affects women with PCOS irrespective of their Body Mass
Index (BMI) (Arasu et al., 2019; Regidor & Schindler, 2016; Song et al., 2017; Stepto et
al., 2013), though a very high percentage of women with PCOS are also obese or
overweight (Legro et al., 2015; Tomlinson et al., 2017). According to the cross-sectional
research study by Stepto et al., (2013) the incidence of insulin resistance in lean women
with PCOS is 75% while in overweight/obese PCOS women levels of insulin resistance
reach 95%. In the overweight control group insulin resistance was only 62% showing the
profound endocrine effects of PCOS (Naderpoor et al., 2015). Insulin resistance is often
underdiagnosed in primary care settings in lean women with PCOS (Song et al., 2017).
Clinically, it is critical to identify insulin resistant infertile women to improve
reproductive outcomes and to reduce the risk of life-effecting metabolic and cardiac
issues (Alebić, Bulum, Stojanović, & Duvnjak, 2014; Tomlinson et al., 2017). The focus
of any treatment regimen for PCOS needs to address insulin resistance.
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A review of available literature illustrates many women with PCOS have a higher
BMI on average, elevated rates of insulin resistance, and higher levels of weight gain
during shorter periods of time. This results in an increased level of clinical severity for a
variety of health issues (Cassar et al., 2016; Tomlinson et al., 2017). Given this
information, a vital clinical focus for a first line treatment should encourage lifestyle
modifications including diet, and exercise to help patients reach a healthier weight
(Alebić et al., 2014; Bergh et al., 2016; Cassar et al., 2016). The addition of insulin
sensitizers along with the lifestyle modifications have resulted in a greater body fat loss,
subsequent to reduced insulin resistance and PCOS symptoms when compared to lifestyle
modifications alone (Alebić et al., 2014; Cassar et al., 2016; Rosenfield & Ehrmann,
2016).
Ideally, the best and most comprehensive lifestyle modification program would be
tailored to the individual patient (Bergh et al., 2016; Marzouk & Sayed, 2015). A
comprehensive plan should address nutrition, physical activity, mental and emotional
health, stress reduction and weight loss strategies in addition to necessary medications;
this combination therapy is intended to help decrease androgen levels and restore
ovulation (Bergh et al., 2016; Kim, Chon, & Lee, 2020). Obesity is highly associated
with PCOS infertility and unfavorably effects reproduction. Weight loss is a vital
component in treating infertile women with PCOS. As little as a 5% to 10% reduction in
total body weight has been shown to restore ovulation and increase fertility (Balen et al.,
2016; Bergh et al., 2016; Einarsson et al., 2017; Marzouk & Sayed, 2015). Weight
reduction has shown to increase the rate of spontaneous pregnancies in PCOS women
(Einarsson et al., 2017). Pharmacotherapy, in the form of insulin sensitizers, in addition
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to lifestyle modifications is recommended to optimize weight loss (Naderpoor et al.,
2015).
For women with PCOS, weight loss is more difficult than for most women
because of the elevated androgen levels. These elevated androgen levels cause increased
appetite and insulin secretion resulting in increased weight gain and retention (Bergh et
al., 2016). Regular low impact physical activity and dietary changes help increase insulin
sensitivity and lower androgen levels resulting in weight loss (Bergh et al., 2016).
Exercise causes a high level of sex binding globulin to be released into the blood
resulting in reduced insulin and testosterone level as well as lower levels of free
androgens in the system (Bergh et al., 2016). Since extreme physical activity (over
exercising) has been shown to be suggestive of negatively impacting fertility, it is
recommended exercising is limited to three to five times a week for 30 minutes a day
(Bergh et al., 2016; Legro et al., 2015).
Along with physical activity, an important part of treating infertile women with
PCOS is to include dietary changes to reduce total body weight (Marzouk & Sayed,
2015). Weight loss from diet changes in women with PCOS has been found to lead to
significant increases in menstrual cycles, including ovulation, and decreases in BMI,
waist circumference, and other androgen related symptoms (Balen et al., 2016; Kim,
Chon, & Lee, 2020; Marzouk & Sayed, 2015). Women with PCOS lose weight when
placed on a dietary protocol of complete proteins and low carbohydrates combined with
an insulin sensitizer such as metformin (Marzouk & Sayed, 2015). The low carbohydrate
and complete protein diet have shown impressive results in lowering body weight, waist
circumference, insulin resistance, and dyslipidemia (Marzouk & Sayed, 2015). Changing
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a patient to a low carbohydrate diet is effective in lowering body mass, in improving
glucose control in diabetic patients and those patients with insulin resistance (Bolla,
Caretto, Laurenzi, Scavini, & Piemonti, 2019). In women with PCOS a low carbohydrate
diet, such as the Keto Diet, can be used as an effective non-pharmacological treatment
(Paoli, Mancin, Giacona, Bianco, & Caprio, 2020). This results in an increase in
estradiol, progesterone, and sex hormone binding globulin and a corresponding decrease
in luteinizing hormone, follicle stimulating hormone, and total and free testosterone
(Paoli et al., 2020). These hormone reductions along with a decrease in blood glucose and
blood insulin levels results in a reduction of PCOS side effects on a woman who is
seeking to achieve better fertility (Paoli et al., 2020).
Waist circumference is a valuable insulin resistance predictor in both women
affected and unaffected by PCOS. As a predictive tool waist circumference can be used
to monitor insulin resistance levels (Marzouk & Sayed, 2015). A reduction in waist
circumference indicated a corresponding reduction in insulin resistance (Marzouk &
Sayed, 2015). A systematic review conducted by Kim, Chon and Lee (2020) found that
lifestyle modifications along with metformin for PCOS resulted in reduced body weight,
reduced insulin resistance, and hyperandrogenism while promoting increased ovulation.
A weight loss study, random controlled trial, also found that obese women with PCOS
who lost weight had a higher number of spontaneous pregnancies (Einarsson et al., 2017).
The two most prescribed medications for inducing ovulation are metformin and
clomiphene citrate (Bergh et al., 2016).
Metformin is shown to be highly effective in treating obese women with PCOS
and is associated with increased ovulation rates and successful clinical pregnancies
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(Bergh et al., 2016). Metformin acts on the body by reducing hepatic gluconeogenesis
and insulin sensitivity that helps to reduce androgen levels and can restore ovulation in up
to 50% of women affected by PCOS (Bergh et al., 2016; Haas & Bentov, 2017;
Rosenfield & Ehrmann, 2016). A course of pre-fertility treatment metformin for three
months, followed by the addition of an ovulation inducing agent, such as clomiphene
citrate has been shown to result in improved pregnancy rates (Diamanti-Kandarakis,
2012).
Clomiphene citrate blocks the estrogen receptors in the hypothalamus leading to
an increase in follicle stimulating hormone and ultimately ovulation (Bergh et al., 2016).
Up to 30% of patients do not resume ovulating with clomiphene citrate as a monotherapy
and require metformin as an adjuvant agent (Bergh et al., 2016; Haas & Bentov, 2017).
Medical management for these patients has traditionally been on an individualized basis
and personalized to their history (Bergh et al., 2016).
This descriptive study project will utilize the PDSA evidence-based framework to
evaluate the program. A historical chart review will be conducted to evaluate the
effectiveness of the current program and promote the best evidence-based practices for
patient centered care. There exists a high level of motivation in infertile women who are
trying to become pregnant. This motivation to conceive a child makes the women more
likely to practice new behavioral skills and lifestyle modifications taught as part of the
treatment regimen (Bergh et al., 2016). Patients with infertility desiring to achieve
pregnancy are highly goal driven and open to following recommendations by their
healthcare providers.
Methods
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Design
This project will evaluate the existing Health and Wellness program, referencing
PDSA Cycle of evidence-based practice, utilizing a descriptive design approach. The
study will be conducted using a retrospective chart review for the first two quarters of
2020 for the Health and Wellness Program. A comparison will also be made between
patient groups with PCOS who participate in the clinic’s life-style modification program
in 2020 compared to PCOS patients who were seen at the clinic in the first two quarters
of 2019 prior to the life-style modification program being implemented.
Setting
This project takes place in an urban Midwestern fertility clinic. Most patients
seeking assistance with fertility issues at this clinic either have insurance or can pay for
services. The clinic offers multiple services to patients including artificial insemination,
invitro fertilization (IVF), and a health and wellness program. The clinic is located in a
city of approximately 126,000 (World Population Review, 2020). The majority of the
fertility patients using the clinic come from within the city limits and surrounding
counties. The average household income for the city where the clinic is located is
$71,311 (World Population Review, 2020). Patients are managed by a supervising
physician with a reproductive endocrinology specialty, a medical laboratory specialist
oversees IVF procedures and semen thawing, and nurses assist patient by conducting
ultrasounds and performing inseminations.
Sample
A convenience sample of women with fertility issues, who also have the diagnosis
of polycystic ovary syndrome, was examined during this project. The sample was
gathered from patients at a midwestern fertility clinic who were taking part in a health
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and wellness program during a 6-month period. A second convenience sample group of
infertile women, seen at the clinic prior to the start of the health and wellness program
was evaluated to compare outcome results with patients who participate in the program.
Patients included in the study will be women between the ages of 18-39 with a diagnosis
of PCOS who were trying to achieve a pregnancy. Patients with partners who have male
factor infertility and patients with uncorrected reproductive abnormalities or are outside
the project age group were excluded.
Data Collection and Analysis
Data will be collected via retrospective medical chart review. Demographic
variables including (age, race/ethnicity, payer status, marital status), and study variables
such as health history, official diagnoses, BMI, insulin resistance status, pregnancy status,
medications, laboratory testing, and records from participation in lifestyle modification
program including attendance were examined (see Table 1).
Patient privacy was protected by de-identifying the records of individual patients
with unique identifiers (A1, A2, A3, etc) and stored on a secured laptop. Descriptive data
and confounder results from the study were displayed in tables, histogram, scatter plots,
pie charts and bar graphs.
Approval Processes
Consent to conduct the project was obtained in May 2020 from the supervising
physician of the fertility clinic where the research is to be conducted. The project topic
and access to the patient charts for review and analysis was approved. The project was
approved by the student’s doctoral committee, and the University of Missouri St. Louis
(UMSL) Graduate School. Quality improvement (QI) determination form was submitted
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for approval by UMSL Institutional Review Board for human subject research prior to
the start of the project. The risk to human subjects is limited because no interventions or
changes in treatment will be taken during the project. The information gathered during
the project was historical in nature. The primary risk to subjects was a potential data
breech of medical information. This risk was addressed by de-identifying patient data
with unique identifiers and all research being retained on a secure, password protected
laptop. The patient data will be retained for a period of three years.
Procedures
Planning consisted of a series of short meetings in May and June of 2020 with the
head physician of the fertility clinic. During these meetings the topic of a program
evaluation for the clinics new lifestyle modification program was broached and items to
study were refined. A separate meeting phone conference in July 2020 with the head of
the Doctor of Nursing Practice program was needed to receive approval for the project
topic and location. A zoom conference with project chair to outline the parameters of the
project was conducted in August 2020. A literature review was conducted to study

current treatments and therapies being utilized for helping PCOS infertile women
conceive. It was decided by the researcher and the committee to conduct a program
evaluation via retrospective chart review to evaluate the effectiveness of the current
lifestyle modification program used at the fertility clinic. In January 2021, a completed
project paper proposal was submitted to committee members for editing and feedback.
The project proposal meeting was conducted and approved with all committee members
present in March 2021. The approved project proposal was submitted to the Institutional
Review Board (IRB) for Quality Improvement project determination. Quality
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Improvement project status not requiring IRB review was granted on May 11, 2021. In
mid-May data collecting and review from the clinic was started with data collating and
analysis completed by the end of the month. In June 2021, the remaining sections of the
paper were written including the program evaluation results.

Results
Of the 368 total patient charts reviewed for inclusion in this study, 163 (44%)
were found to have met study admission criteria. Patients were broken down into
calendar year quarters in order for each quarter to be compared to the same quarter the
following year and to attempt to account for COVID 19 variances. The first two quarters
of each year were assessed for patterns.
The first quarter of 2019 contained 40 patients who met criteria with an age range
between 21 and 39 years old. The average patient age was 30.1 years. 35 (88%) patients
were of Caucasian decent, 3 were African America, 1 was Asia, and 1 identified as mixed
race. The majority 93% (n=37) had some form of insurance coverage. Marital status
varied but the majority were married or in a committed relationship 80% (n=32), while
the remainder were pursuing fertility treatment without a partner. 68% (n=27) of patients
had official diagnoses of PCOS, the other 32% (n=13) were clinically suspected to have
PCOS.
Patient starting BMI ranged from 20.6 to 47 with an average BMI of 31.1. Due to
data gaps ending BMI’s and weights did not accurately reflect the included patients.
Starting weights ranged from 147 to 297 pounds during this quarter with an average
patient weight of 197.6 pounds. Of the comorbidities listed in the medical charts’ obesity
was by far the most common with 68% (n=27) patients being labelled obese to morbidly

15
EVALUATION OF LIFESTYLE MODIFICATION
obese. The plans for treatment included 20 patients being referred for weight loss, 21
having an end goal of IUI, 7 utilizing IVF. Twenty-seven of these patients were
prescribed or had fertility medications in their treatment plan. During treatment patients
lost an average of 8.5 pounds with the range of weight change being -44 to +20 pounds.
Ending weights were only able to be located for 20 of the 40 patients included in the
study for first quarter 2019.
Of the 13 patients who did end up losing weight, 11 of them became pregnant.
Then 45% (n=18) of patients were clinically identified as being diabetic or insulin
resistant. Fifty-three percent (n=21) of patients had a history of previous positive
pregnancies, some went to term and delivery while others resulted in miscarriage. Prior to
seeking fertility services, 30% (n=12) of patients had a history of one or more
miscarriages. While 50% (n=20) patients had a positive pregnancy test during treatment
at the fertility clinic, this does not mean they went to term, but does indicate the patients
were able to resume ovulation with treatment. Of the 40 patients, 55% (n=22) continued
to seek services at the clinic with 45% (n=18) patients being lost to fertility clinic
services.
The second quarter of 2019 also contained 40 patients who met criteria with an
age range between 22 and 37 years old. The average patient age was 28.2 years. 88%
(n=35) patients were of Caucasian decent, 1 was African America, and 4 were Hispanic.
The majority 93% (n=37) had some form of insurance coverage. Marital status varied but
the majority were married or in a committed relationship 83% (n=33), while the
remainder were pursuing fertility treatment without a partner. 80% (n=32) patients had
official diagnoses of PCOS, the other 20% (n=8) were clinically suspected to have PCOS.
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Twenty percent (n=8) of the patients were identified as having lean type PCOS. Patient
starting BMI ranged from 17.9 to 55.3 with an average BMI of 31.9.
Due to data gaps ending BMI’s and weights did not accurately reflect the included
patients. Starting weights ranged from 111 to 322 during the second quarter with an
average patient weight of 191.6 pounds. Of the comorbidities listed in the medical charts’
obesity was by far the most common with 50% (n=20) patients being labelled obese to
morbidly obese.
The plans for treatment included 65% (n=26) being referred for weight loss, 33%
(n=13) having an end goal of IUI, 1% (n=4) utilizing IVF. With 85% (n=34) of these
patients were prescribed or had fertility medications in their treatment plan. During
treatment patients lost an average of 8.3 pounds with the range of weight change being 22.5 to +23 pounds. Ending weights were only able to be located for 19 of the 40 patients
included in the study for second quarter 2019. Of the 15 patients who did end up losing
weight, 14 of them became pregnant. Forty-five percent (n=18) of patients were clinically
identified as being diabetic or insulin resistant. There was 48% (n=19) of patients who
had a history of previous positive pregnancies, some went to term and delivery others
resulted in miscarriage. There was 33% (n=13) of patients who had a history of one or
more miscarriages prior to seeking fertility services. Then 48% (n=19) patients had a
positive pregnancy test during treatment at the fertility clinic, this does not mean they
went to term, but does indicate the patients were able to resume ovulation with treatment.
Of the 40 patients, 55% (n=22) continued to seek services at the clinic with 45% (n=18)
patients being lost to fertility clinic services.
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The first quarter of 2020 contained 45 patients who met criteria with an age range
between 22 and 39 years old. The average patient age was 29.3 years. Ninety-eight
percent (n=44) patients were of Caucasian decent, and 1 identified as being of mixed
race. The majority, 91% (n=41) had some form of insurance coverage. Marital status
varied but the majority were married or in a committed relationship 78% (n=35), while
the remainder were pursuing fertility treatment without a partner. 73% (n=33) patients
had official diagnoses of PCOS, the other 27% (n=12) were clinically suspected to have
PCOS. Eighteen percent (n=8) of the patients were identified as having lean type PCOS.
Patient starting BMI ranged from 20.7 to 55.4 with an average BMI of 41.4. Due to data
gaps ending BMI’s and weights did not accurately reflect the included patients. Starting
weights ranged from 128 to 370 during this quarter with an average patient weight of
231.8 pounds. Of the comorbidities listed in the medical charts’ obesity was by far the
most common with 73% (n=33) patients being labelled obese to morbidly obese.
The plans for treatment included 73% (n=33) being referred for weight loss, 44%
(n=20) having an end goal of IUI, 20% (n=9) utilizing IVF. Fifty-six percent (n=25) of
these patients were prescribed or had fertility medications in their treatment plan. During
treatment patients lost an average of 16.1 pounds with the range of weight change being 69 to +10 pounds. Ending weights were only able to be located for 23 of the 45 patients
included in the study for first quarter 2020. Of the 19 patients who did end up losing
weight, 14 of them became pregnant. There were 36% (n=16) patients clinically
identified as being diabetic or insulin resistant. While 47% (n=21) of patients who had a
history of previous positive pregnancies, some went to term and delivery others resulted
in miscarriage. There were 31% (n=14) patients who had a history of one or more
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miscarriages prior to seeking fertility services. There were 42% (n=19) patients who had
a positive pregnancy test during treatment at the fertility clinic, this does not mean they
went to term, but does indicate the patients were able to resume ovulation with treatment.
Of the 45 patients, 55% (n=25) continued to seek services at the clinic with 45% (n=20)
patients being lost to fertility clinic services.
The second quarter of 2020 contained 38 patients who met criteria with an age
range between 20 and 39 years old. The average patient age was 30.1 years. 97% (n=37)
patients were of Caucasian decent, and one was mixed race. The majority 89% (n=34)
had some form of insurance coverage. Marital status varied but the majority were married
or in a committed relationship 84% (n=32), while the remainder were pursuing fertility
treatment without a partner. 45% (n=17) patients had official diagnoses of PCOS, the
other 55% (n=21) were clinically suspected to have PCOS. Eleven percent (n=4) of the
patients were identified as having lean type PCOS.
Patient starting BMI ranged from 19.8 to 50.3 with an average BMI of 33.3. Due
to data gaps ending BMI’s and weights did not accurately reflect the included patients.
Starting weights ranged from 133 to 310 during this quarter with an average patient
weight of 217.8 pounds. Of the comorbidities listed in the medical charts’ obesity was by
far the most common with 71% (n=27) patients being labelled obese to morbidly obese.
The plans for treatment included 66% (n=25) being referred for weight loss, 47%
(n=18) having an end goal of IUI, 18% (n=7) utilizing IVF. 68% (n=26) of these patients
were prescribed or had fertility medications in their treatment plan. During treatment
patients lost an average of 23.8 pounds with the range of weight change being -43.8 to
+13 pounds. Ending weights were only able to be located for 14 of the 38 patients
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included in the study for second quarter 2020. Of the 11 patients who did end up losing
weight, 5 of them became pregnant. There were 47% (n=18) patients who were clinically
identified as being diabetic or insulin resistant. While 47% (n=18) patients had a history
of previous positive pregnancies, some went to term and delivery, others resulted in
miscarriage. Thirty-seven percent (n=14) of patients who had a history of one or more
miscarriages prior to seeking fertility services. While 24% (n=9) of patients had a
positive pregnancy test during treatment at the fertility clinic, this does not mean they
went to term, but does indicate the patients were able to resume ovulation with treatment.
Of the 38 patients, 45% (n=17) continued to seek services at the clinic with 55% (n=21)
of patients being lost to fertility clinic services.
Several overall themes can be concluded from assessing the data gathered during
the first two quarters of 2019 and 2020. The first is that when patients lose weight, they
are more likely to start ovulating and become pregnant. The second is there are an
overwhelming number of patients seeking fertility treatment at the Midwestern clinic
who are obese or morbidly obese in addition to having polycystic ovarian syndrome.
Other common comorbid conditions that frequently showed up in the patient population
meeting criteria for the study included being underweight, endometriosis,
hypothyroidism, a history of chlamydia, advanced maternal age, tubal issues, peritoneal
adhesion's, repeated pregnancy loss, anxiety, depression, and hypertension.
Potentially due to COVID-19 there were fewer patients seen during the second
quarter of 2020. However, the patients who were seen where unhealthier and had a higher
starting weight. This is borne out by the elevated average starting BMI and weight for
this quarter. The second quarter of 2020 resulted in far more unofficial diagnosis’ of
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PCOS because of virtual consults and a lack of initial physical exam. This resulted in
patients not having an official diagnosis of PCOS.
When addressing the information gathered from the Health and Wellness program
results were mixed. During the first quarter of 2020, 10 patients participated in the health
and Wellness program. Since then, nine of those patients have been archived and no
longer participate in the program. Five of the patients achieved a pregnancy, two were
spontaneous and two were the result of intrauterine insemination (IUI), the fifth patient
had a biochemical pregnancy after a IUI cycle. All ten of the patients did lose some
weight. Patients participated in the Health and Wellness program for between two and 24
sessions. Disregarding outliers who had a far higher number of sessions the average
number of sessions varied between two and six.
There were eight patients from the second quarter of 2020, who have been
confirmed in the program. Of those eight patients, six are now archived and no longer
participating in the program and only two of the eight have achieved a pregnancy. One of
the pregnancies was biochemical and the other pregnancy was achieved using in vitro
fertilization. Four of the eight patients lost weight participating in the program, three of
the patients ended up gaining weight, and for the last patient no recorded weight was able
to be located after the initial weigh-in at the fertility clinic. The number of sessions
patients participated in with the Health and Wellness program varied between one session
and 18. The more typical number of sessions participated in seems to be between three
and six.
Of the 58 patients who were referred to the Health and Wellness program for
weight loss, only 18 patients participated. The current Health and Wellness program

21
EVALUATION OF LIFESTYLE MODIFICATION
focuses solely on nutrition utilizing the ketogenic diet. Areas of a lifestyle modification
program that are not addressed include physical activity, stress reduction, mental health
wellness, and monitoring/treatment of comorbid medical conditions.
Discussion
This program evaluation project of the Health and Wellness program
implemented at a Midwestern fertility clinic evaluated patient data for the first two
quarters of 2019 and 2020. The goal of this evaluation was to gather baseline data both
pre and post implementation of the Health and Wellness program. Analyzing the data
quarter by quarter allowed for unexpected changes due to the COVID-19 pandemic.
As expected, numbers were reduced slightly but overall, the number of patients
seen at the clinic remained steady. The interesting thing that did occur in the data was
that patient body mass indexes and weights shifted up from the other three quarters
evaluated. This potentially indicates that patients with more severe medical problems are
more likely to seek treatment, even elective treatment during a pandemic, when compared
to patients who are not as severely ill.
Overall, as expected the patients who lost weight had a higher likelihood of
becoming pregnant. Participation in the Health and Wellness program did result in
several patients losing weight and achieving a pregnancy. Of the 18 patients who
participated in the Health and Wellness program 7 patients achieved a positive pregnancy
result, two of those were biochemical. If you remove the biochemical pregnancies the
success rate is 28%. However, when compared to the number of patients from the first
two quarters of 2019 who lost weight (n=32) and became pregnant (n=25) the clinic had a
78% pregnancy success rate. It is possible that more patients in the first two quarters of
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2019 lost weight than were indicated in the data. In some quarters half the patients did
not have a follow-up weight listed in their charts. However, hypothetically doubling the
number of patients who lost weight (n=64) the pregnancy success rate would still be
40%.
Barriers identified for getting patients enrolled and participating in the health and
Wellness program include the lack of follow up, issues with scheduling initial interviews,
the program only being offered via distance consultations, cost, and a lack of wellrounded services usually present during a lifestyle modification program. Often patients
with fertility issues, who also have PCOS, suffer from comorbid depression or anxiety.
Other factors related to the Health and Wellness program that showed up in the
chart review indicate that the program is being underutilized. There were instances when
patients with lean PCOS, who were underweight or had a lower BMI, would have
benefited from a referral to the Health and Wellness program. In addition many of the
patients preferred to have better access to their Health and Wellness coach and did not
wish to pursue a program that was distant based.
The impact of the COVID-19 pandemic on the sample from 2020 did affect the
results of the study, especially for the second quarter of 2020, when many of the
appointments had to be done via Telehealth. Appointments conducted via Telehealth did
not elicit the same amount of data as in a traditional clinic visit. Namely vital statistics
such as height, weight, and body type were often an estimate. There were many instances
where data was missing from the charts, most notably weights. Often the first weight
when the patient was seen initially at the clinic was the only weight able to be located
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within the chart unless the patient became pregnant. Keeping track of a patient's weight
changes are vital when addressing fertility issues.
Conclusion
The Health and Wellness program associated with this Midwestern fertility clinic
shows great promise but is currently underdelivering. Most of the patients participating in
the Health and Wellness program are losing weight, but the focus exclusively on the
ketogenic diet is failing some of the other patients. The Health and Wellness program
needs to expand into a true lifestyle modification program that goes beyond nutrition and
includes physical activity, stress reduction, mental health, patient education, and
monitoring comorbid medical conditions such as hypertension and blood glucose levels.
One strength of this study was the ability to evaluate data from both before and after the
Health and Wellness program was implemented to see the changes that occurred in health
outcomes. The implementation of a well-rounded Health and Wellness program is
recommended for the coordination of care and the improvement of patient health
outcomes.
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Appendix A
Table 1 Data Collection Instrument
Patient
Data Categories
Age
Race (White-1, African American-2, Asian-3,
Hispanic-4, Mixed-5)
Payer Status (Private Pay-1, Private Insurance-2,
Medicare/Medicaid-3)
Martital Status (Single-1, Married-2, Divorced-3)
PCOS Diagnosis (Official-1, Suspected-2, None3)
BMI Before LMP
BMI After LMP
Weight Before LMP
Weight After LMP
Difference in Weight- Before and After
Diabetes Status (DM1-1, DM2-2, None-3, IR-4)
A1C
Pregnancy Status Post LMP
Positive Pregnancy Hx (Yes-1, No-2)
Medications
Attendance at H/W (Number of Sessions)
Resumption of Mensural Cycle (Yes-1, No-2)
Participated in Lifestyle Modification Program
(Yes-1, No-2)
Comorbid Diagnosis
Any Lab Tests Performed

Continued To Seek Services at MF clinic
General Plan
Preg Hx
miscarriages
Live births

A1

A2

A3

A4

A5

A6

A7

A8
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Appendix B
Table 2 Demographic Data
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Appendix C
Table 3 Patient Retention Rates for Fertility Clinic
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Appendix D
Table 4 Pregnancy Results for Patients in Health and Wellness Program
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Appendix E
Table 5 Pregnancy Results After Weight Loss

